NCT04405817

Brief Summary

Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
8.4 years until next milestone

First Submitted

Initial submission to the registry

May 26, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 28, 2020

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 28, 2020

Status Verified

May 1, 2020

Enrollment Period

14 years

First QC Date

May 26, 2020

Last Update Submit

May 26, 2020

Conditions

Cardiogenic ShockCardiac ArrestHeart FailureAcute Respiratory FailureAcute Respiratory Distress Syndrome

Outcome Measures

Primary Outcomes (1)

  • Composite of death from any cause, resuscitated circulatory arrest, and implantation of another mechanical circulatory support device

    30 days after ECMO implantation

Secondary Outcomes (2)

  • All-cause mortality

    30 days after ECMO implantation

  • All-cause mortality

    12 months after ECMO implantation

Interventions

ECMODEVICE

ECMO for circulatory and/or respiratory support

Eligibility Criteria

Age1 Year - 100 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients receiving ECMO for circulatory and/or respiratory support

You may qualify if:

  • Patients receiving ECMO for circulatory and/or respiratory support

You may not qualify if:

  • Refusal of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The first affiliated hospital of nanjing medical university

Nanjing, Jiangsu, 210029, China

RECRUITING

MeSH Terms

Conditions

Shock, CardiogenicHeart ArrestHeart FailureRespiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisShockLung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Yong-feng Shao

    The First Affiliated Hospital with Nanjing Medical University

    STUDY DIRECTOR

Central Study Contacts

Hong Liu, MD

CONTACT

18801281613DR.HONGLIU@FOXMAIL.COM

Yong-feng Shao, MD

CONTACT

02568303100yfshaojph@sina.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator of Department of Cardiac Surgery

Study Record Dates

First Submitted

May 26, 2020

First Posted

May 28, 2020

Study Start

January 1, 2012

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 28, 2020

Record last verified: 2020-05

Locations

CN(1)